<?xml version="1.0" encoding="UTF-8"?>
<ref id="B60-marinedrugs-17-00567">
 <label>60.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>S.K.</given-names>
   </name>
   <name>
    <surname>Palmer</surname>
    <given-names>K.E.</given-names>
   </name>
   <name>
    <surname>Devlin</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Rohan</surname>
    <given-names>L.C.</given-names>
   </name>
  </person-group>
  <article-title>Design of poly(lactic-co-glycolic acid) (PLGA) nanoparticles for vaginal co-delivery of griffithsin and dapivirine and their synergistic effect for HIV prophylaxis</article-title>
  <source>Pharmaceutics</source>
  <year>2019</year>
  <volume>11</volume>
  <elocation-id>184</elocation-id>
  <pub-id pub-id-type="doi">10.3390/pharmaceutics11040184</pub-id>
 </element-citation>
</ref>
